PRAME-EP461

Testis stain with anti PRAME

PRAME-EP461

PRAME (PReferentially-expressed Antigen in MElanoma) is a gene encoded on the 22q11-22 chromosomal sequence and encodes a 509 amino acid residue protein. PRAME is a melanoma antigen that is preferentially expressed in tumors and is recognized by cytotoxic T lymphocytes. PRAME can be used to distinguish between malignant melanoma cells and nevus cells, and therefore may be useful for diagnostic purposes to support a suspected case of melanoma. PRAME is considered a cancer-testis antigen (CTA) and is not strongly expressed in most other normal tissues. PRAME is positively expressed in about half of uveal melanomas, and the majority of mucosal melanomas.

  • Description
  • Specifications
  • Ordering Information

PRAME (PReferentially-expressed Antigen in MElanoma) is a gene encoded on the 22q11-22 chromosomal sequence and encodes a 509 amino acid residue protein. PRAME is a melanoma antigen that is preferentially expressed in tumors and is recognized by cytotoxic T lymphocytes. PRAME can be used to distinguish between malignant melanoma cells and nevus cells, and therefore may be useful for diagnostic purposes to support a suspected case of melanoma. PRAME is considered a cancer-testis antigen (CTA) and is not strongly expressed in most other normal tissues. PRAME is positively expressed in about half of uveal melanomas, and the majority of mucosal melanomas.

  • Source
    Rabbit Monoclonal
  • Clone
    EP461
  • Class
    IVD
  • Isotype
    Rabbit, IgG
  • Tested Reactivity
    Human, FFPE
  • Localization
    Nucleus and/or Membrane
  • Positive Control
    Melanoma, Testis
  • Catalog
    Pack Size
  • MR1318-3ml
    3ml (RTU)
  • MR1318-6ml
    6ml (RTU)
  • MRC1318-0.1ml
    0.1ml (Conc.)
  • MRC1318-0.5ml
    0.5ml (Conc.)
  • MRC1318-1ml
    1ml (Conc.)
  • MRH1318-3ml
    3ml (RTU)
  • MRH1318-6ml
    6ml (RTU)